SA
Sign upLog In

Regeneron Pharmaceuticals (REGN)

Revenue

$5.12B

Quarterly · Period ending: · USD

REGN logo

REGN Revenue

Latest reported$5.12B
REGN Quarterly Revenue ($1.20M → $5.12B)
High-resolution chart · PNG

REGN revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Revenue — Quarterly (USD)
Period endingRevenue (USD)
5,115,800,000
4,290,700,000
3,605,400,000
3,884,300,000
3,754,300,000
3,675,600,000
3,028,700,000
3,789,200,000
3,720,700,000
3,547,100,000
3,145,000,000
3,434,300,000
3,362,700,000
3,158,100,000
3,162,100,000
3,414,400,000
2,936,200,000
2,857,200,000
2,965,100,000
4,951,700,000
3,452,800,000
5,138,500,000
2,528,700,000
2,422,900,000
2,294,000,000
1,952,000,000
1,828,200,000
1,863,500,000
1,743,700,000
1,577,800,000
1,372,600,000
1,927,800,000
1,663,496,000
1,608,022,000
1,511,485,000
1,582,447,000
1,500,673,000
1,470,116,000
1,318,991,000
1,226,827,000
1,220,122,000
1,212,629,000
1,200,849,000
1,098,077,000
1,137,422,000
998,617,000
869,612,000
802,329,000
725,788,000
665,700,000
625,740,000
610,412,000
597,027,000
457,642,000
439,664,000
414,602,000
427,687,000
304,399,000
231,789,000
122,977,000
102,833,000
107,810,000
112,204,000
133,675,000
105,979,000
115,886,000
103,534,000
96,800,000
117,455,000
90,032,000
74,981,000
55,837,000
65,584,000
60,653,000
56,383,000
64,730,000
22,311,000
22,195,000
15,788,000
10,346,000
15,624,000
19,258,000
18,219,000
17,424,000
16,194,000
16,366,000
16,209,000
47,090,000
36,519,000
28,418,000
61,990,000
21,272,000
17,392,000
10,532,000
10,136,000
4,912,000
6,566,000
5,569,000
4,941,000
4,401,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.